US diagnostics manufacturers asked to provide more point-of-care data ahead of clinic & GP use
This article was originally published in Clinica
Executive Summary
The US FDA is proposing that diagnostics manufacturers provide substantially more data on how well their laboratory tests perform in the point-of-care setting before the products can be used by healthcare personnel in community clinics and physician offices.